Wang Wei, Liu Bowei, Sun Suofeng, Lan Ling, Chen Yu, Han Shuangyin, Li Xiuling, Li Zhaoshen
Department of Gastroenterology, Changhai Hospital, Second Military Medical University/Naval Medical University, Shanghai 200433, People's Republic of China.
Department of Gastroenterology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, Henan 450003, People's Republic of China.
Onco Targets Ther. 2020 Feb 24;13:1649-1659. doi: 10.2147/OTT.S231153. eCollection 2020.
5-Fluorouracil (5-Fu) has been applied to treat pancreatic cancer, which is one of the most common types of digestive system tumors. Evidence has shown that miR-486-5p could promote the proliferation of pancreatic cancer cells. Therefore, this study aimed to investigate whether downregulation of miR-486-5p could enhance the anti-tumor effect of 5-Fu on pancreatic cancer cells.
Cell Counting Kit 8 assay, flow cytometry and wound healing assays were used to detect proliferation, apoptosis and migration in PANC-1 cells. The expressions of Bcl-2, Bax, cleaved caspase 3, PTEN, p-Akt and p-ERK in PANC-1 cells were detected with Western blot assay.
In this study, the inhibitory effects of 5-Fu on the proliferation, migration and invasion of PANC-1 cells were significantly enhanced following transfection with miR-486-5p antagonist. In addition, downregulation of miR-486-5p markedly enhanced the pro-apoptosis effect of 5-Fu on PANC-1 cells. Moreover, bioinformatics analysis and luciferase reporter assay identified that PTEN was the directly binding target of miR-486-5p. Meanwhile, downregulation of miR-486-5p markedly enhanced the anti-tumor effect of 5-Fu in PANC-1 cells via upregulation of the level of PTEN, and downregulation of the expressions of p-ERK and p-Akt. In vivo experiments confirmed that knockdown of miR-486-5p could enhance the anti-tumor effect of 5-Fu in PANC-1 xenograft model.
We found that the downregulation of miR-486-5p could enhance the anti-tumor effect of 5-Fu on pancreatic cancer cells. Therefore, miR-486-5p antagonist plus 5-Fu might be considered as a potential therapeutic strategy for the treatment of pancreatic cancer.
5-氟尿嘧啶(5-Fu)已被应用于治疗胰腺癌,胰腺癌是消化系统最常见的肿瘤类型之一。有证据表明,miR-486-5p可促进胰腺癌细胞的增殖。因此,本研究旨在探讨下调miR-486-5p是否能增强5-Fu对胰腺癌细胞的抗肿瘤作用。
采用细胞计数试剂盒8检测、流式细胞术和伤口愈合试验检测PANC-1细胞的增殖、凋亡和迁移情况。用蛋白质免疫印迹法检测PANC-1细胞中Bcl-2、Bax、裂解的半胱天冬酶3、PTEN、p-Akt和p-ERK的表达。
在本研究中,用miR-486-5p拮抗剂转染后,5-Fu对PANC-1细胞增殖、迁移和侵袭的抑制作用显著增强。此外,miR-486-5p的下调显著增强了5-Fu对PANC-1细胞的促凋亡作用。此外,生物信息学分析和荧光素酶报告基因检测确定PTEN是miR-486-5p的直接结合靶点。同时,miR-486-5p的下调通过上调PTEN水平、下调p-ERK和p-Akt的表达,显著增强了5-Fu对PANC-1细胞的抗肿瘤作用。体内实验证实,敲低miR-486-5p可增强5-Fu在PANC-1异种移植模型中的抗肿瘤作用。
我们发现下调miR-486-5p可增强5-Fu对胰腺癌细胞的抗肿瘤作用。因此,miR-486-5p拮抗剂联合5-Fu可能被认为是治疗胰腺癌的一种潜在治疗策略。